{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:24:20Z","timestamp":1768440260093,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jbspin.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T13:16:56Z","timestamp":1528291016000},"page":"131-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can drugs trigger CPPD acute attacks?"],"prefix":"10.1016","volume":"86","author":[{"given":"Yun-Ju","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9770-5730","authenticated-orcid":false,"given":"Chang-Fu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2018.05.010_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European League against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/ard.62.6.513","article-title":"UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte","volume":"62","author":"Neame","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0155","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/acr.23160","article-title":"Calcium pyrophosphate deposition disease and associated medical comorbidities: a National Cross-Sectional Study of US veterans","volume":"69","author":"Kleiber Balderrama","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0160","first-page":"570","article-title":"The high prevalence of pathologic calcium crystals in pre-operative knees","volume":"29","author":"Derfus","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0165","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","article-title":"Inorganic pyrophosphate generation and disposition in pathophysiology","volume":"281","author":"Terkeltaub","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0170","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4453","article-title":"The association between ANKH promoter polymorphism and chondrocalcinosis is independent of age and osteoarthritis: results of a case-control study","volume":"16","author":"Abhishek","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0175","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1073\/pnas.142063399","article-title":"Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization","volume":"99","author":"Hessle","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0185","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.joca.2009.04.022","article-title":"Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis","volume":"17","author":"Liu","year":"2009","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0190","first-page":"817","article-title":"Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosis","volume":"89","author":"Spilberg","year":"1977","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0195","first-page":"32","article-title":"Update on calcium pyrophosphate deposition","volume":"34","author":"Abhishek","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0200","first-page":"571","article-title":"Chondrocalcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease","volume":"65","author":"Punzi","year":"1998","journal-title":"Rev Rhumatisme (English ed)"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0205","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/rheumatology\/kes204","article-title":"Risk factors for pseudogout in the general population","volume":"51","author":"Rho","year":"2012","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/s10165-006-0468-4","article-title":"Pseudogout attack induced during etidronate disodium therapy","volume":"16","author":"Watanabe","year":"2006","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jbspin.2016.11.004","article-title":"First cases of calcium pyrophosphate deposition disease after zoledronic acid therapy","volume":"84","author":"Couture","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/rheumatology\/keh428","article-title":"Weekly alendronate-induced acute pseudogout","volume":"44","author":"Young-Min","year":"2005","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0225","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3899\/jrheum.091016","article-title":"Acute pseudogout following intravenous neridronate for osteoporosis","volume":"37","author":"Carda","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0230","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10067-008-0923-z","article-title":"Acute pseudogout after pamidronate infusion","volume":"27","author":"Wendling","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0235","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/106002809703100422","article-title":"Acute pseudogout as a complication of pamidronate","volume":"31","author":"Malnick","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/003693309103600207","article-title":"Pseudogout associated with the use of cyclical etidronate therapy","volume":"36","author":"Gallacher","year":"1991","journal-title":"Scott Med J"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0245","doi-asserted-by":"crossref","first-page":"e6177","DOI":"10.1097\/MD.0000000000006177","article-title":"Incident acute pseudogout and prior bisphosphonate use: matched case-control study in the UK-Clinical Practice Research Datalink","volume":"96","author":"Roddy","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0250","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0255","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/1529-0131(199906)42:6<1302::AID-ANR33>3.0.CO;2-4","article-title":"Recurrent acute calcium pyrophosphate dihydrate arthritis following intraarticular hyaluronate injection","volume":"42","author":"Disla","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0260","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/1529-0131(199904)42:3<594::AID-ANR40>3.0.CO;2-P","article-title":"Pyrophosphate arthritis after intraarticular injection of hyaluronan: comment on the article by Luzar and Altawil","volume":"42","author":"Maillefert","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0265","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s100670050034","article-title":"Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of hylan G-F 20 (Synvisc)","volume":"19","author":"Kroesen","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0270","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9343(99)00255-7","article-title":"Acute pseudogout following intra-articular injection of high molecular weight hyaluronic acid","volume":"107","author":"Ali","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0275","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3143\/geriatrics.36.572","article-title":"An elderly case with pseudogout exacerbated by the administration of granulocyte-colony stimulating factor during drug-induced granulocytopenia","volume":"36","author":"Yamamoto","year":"1999","journal-title":"Nihon Ronen Igakkai zasshi"},{"key":"10.1016\/j.jbspin.2018.05.010_bib0280","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/s10165-007-0601-z","article-title":"Consecutive pseudogout attacks after repetitive granulocyte colony-stimulating factor administration for neutropenia","volume":"17","author":"Ames","year":"2007","journal-title":"Mod Rheumato"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18301106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X18301106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T17:49:20Z","timestamp":1551462560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X18301106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1297319X18301106"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.05.010","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can drugs trigger CPPD acute attacks?","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}